384 related articles for article (PubMed ID: 22525255)
1. Findings of computed tomography in stage IIB and IIC melanoma: a six-year retrospective study in the South-East of Scotland.
Orfaniotis G; Mennie JC; Fairbairn N; Butterworth M
J Plast Reconstr Aesthet Surg; 2012 Sep; 65(9):1216-9. PubMed ID: 22525255
[TBL] [Abstract][Full Text] [Related]
2. Does staging computered tomography change management in thick malignant melanoma?
Sawyer A; McGoldrick RB; Mackey SP; Allan R; Powell B
J Plast Reconstr Aesthet Surg; 2009 Apr; 62(4):453-6. PubMed ID: 18468970
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of imaging strategy for an intensive follow-up of patients with American Joint Committee on Cancer stage IIB, IIC and III malignant melanoma.
Podlipnik S; Moreno-Ramírez D; Carrera C; Barreiro A; Manubens E; Ferrandiz-Pulido L; Sánchez M; Vidal-Sicart S; Malvehy J; Puig S
Br J Dermatol; 2019 May; 180(5):1190-1197. PubMed ID: 29876940
[TBL] [Abstract][Full Text] [Related]
4. FDG PET in early stage cutaneous malignant melanoma.
McIvor J; Siew T; Campbell A; McCarthy M
J Med Imaging Radiat Oncol; 2014 Apr; 58(2):149-54; quiz 266. PubMed ID: 24690243
[TBL] [Abstract][Full Text] [Related]
5.
Jaeger ZJ; Williams GA; Chen L; Mhlanga JC; Cornelius LA; Fields RC
J Surg Oncol; 2022 Mar; 125(3):525-534. PubMed ID: 34741547
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of imaging studies for initial staging of T2b to T4b melanoma patients: A cross-sectional study.
Riquelme-Mc Loughlin C; Podlipnik S; Bosch-Amate X; Riera-Monroig J; Barreiro A; Espinosa N; Moreno-Ramírez D; Giavedoni P; Vilana R; Sánchez M; Vidal-Sicart S; Carrera C; Malvehy J; Puig S
J Am Acad Dermatol; 2019 Dec; 81(6):1330-1338. PubMed ID: 31163236
[TBL] [Abstract][Full Text] [Related]
7. Computed tomography in staging of patients with melanoma metastatic to the regional nodes.
Johnson TM; Fader DJ; Chang AE; Yahanda A; Smith JW; Hamlet KR; Sondak VK
Ann Surg Oncol; 1997; 4(5):396-402. PubMed ID: 9259966
[TBL] [Abstract][Full Text] [Related]
8. The role of routine imaging in pediatric cutaneous melanoma.
Halalsheh H; Kaste SC; Navid F; Bahrami A; Shulkin BL; Rao B; Kunkel M; Artz N; Pappo A
Pediatr Blood Cancer; 2018 Dec; 65(12):e27412. PubMed ID: 30124237
[TBL] [Abstract][Full Text] [Related]
9. [Impact of whole body magnetic resonance imaging (MRI) in the management of melanoma patients, in comparison with positron emission tomography/computed tomography (TEP/CT) and CT].
Dellestable P; Granel-Brocard F; Rat AC; Olivier P; Régent D; Schmutz JL
Ann Dermatol Venereol; 2011 May; 138(5):377-83. PubMed ID: 21570561
[TBL] [Abstract][Full Text] [Related]
10. Whole body PET/CT in the follow-up of asymptomatic patients with stage IIB-IIIB cutaneous melanoma
Koskivuo I; Kemppainen J; Giordano S; Seppänen M; Veräjänkorva E; Vihinen P; Minn H
Acta Oncol; 2016 Nov; 55(11):1355-1359. PubMed ID: 27553064
[TBL] [Abstract][Full Text] [Related]
11. Computed tomography in evaluation of patients with stage III melanoma.
Kuvshinoff BW; Kurtz C; Coit DG
Ann Surg Oncol; 1997; 4(3):252-8. PubMed ID: 9142387
[TBL] [Abstract][Full Text] [Related]
12. Role of chest computed tomography in head and neck cancer.
Hsu YB; Chu PY; Liu JC; Lan MC; Chang SY; Tsai TL; Huang JL; Wang YF; Tai SK
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1050-4. PubMed ID: 18936349
[TBL] [Abstract][Full Text] [Related]
13. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography is superior to computed tomography for metastatic detection in melanoma patients.
Swetter SM; Carroll LA; Johnson DL; Segall GM
Ann Surg Oncol; 2002 Aug; 9(7):646-53. PubMed ID: 12167578
[TBL] [Abstract][Full Text] [Related]
15. Surveillance strategies in the follow-up of melanoma patients: too much or not enough?
Kurtz J; Beasley GM; Agnese D; Kendra K; Olencki TE; Terando A; Howard JH
J Surg Res; 2017 Jun; 214():32-37. PubMed ID: 28624057
[TBL] [Abstract][Full Text] [Related]
16. The role of positron emission tomography with computed tomography in the follow-up of asymptomatic cutaneous malignant melanoma patients with a high risk of disease recurrence.
Abbott RA; Acland KM; Harries M; O'Doherty M
Melanoma Res; 2011 Oct; 21(5):446-9. PubMed ID: 21849913
[TBL] [Abstract][Full Text] [Related]
17. Clinical value of including the head and lower extremities in 18F-FDG PET/CT imaging for patients with malignant melanoma.
Niederkohr RD; Rosenberg J; Shabo G; Quon A
Nucl Med Commun; 2007 Sep; 28(9):688-95. PubMed ID: 17667747
[TBL] [Abstract][Full Text] [Related]
18. Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma.
Baker JJ; Meyers MO; Frank J; Amos KD; Stitzenberg KB; Ollila DW
Am J Surg; 2014 Apr; 207(4):549-54. PubMed ID: 24674829
[TBL] [Abstract][Full Text] [Related]
19. Routine positron emission tomography and positron emission tomography/computed tomography in melanoma staging with positive sentinel node biopsy is of limited benefit.
Constantinidou A; Hofman M; O'Doherty M; Acland KM; Healy C; Harries M
Melanoma Res; 2008 Feb; 18(1):56-60. PubMed ID: 18227709
[TBL] [Abstract][Full Text] [Related]
20. Performance of diagnostic tests in an intensive follow-up protocol for patients with American Joint Committee on Cancer (AJCC) stage IIB, IIC, and III localized primary melanoma: A prospective cohort study.
Podlipnik S; Carrera C; Sánchez M; Arguis P; Olondo ML; Vilana R; Rull R; Vidal-Sicart S; Vilalta A; Conill C; Malvehy J; Puig S
J Am Acad Dermatol; 2016 Sep; 75(3):516-524. PubMed ID: 27183845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
